Back
Quantum Computing 10K Form
Buy
59
QUBT
Quantum Computing
Last Price:
$8.47
Seasonality Move:
9.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-03-27 | 10K | QUBT/Quantum Computing Annual |
2019-11-13 | 10Q | QUBT/Quantum Computing Quarterly |
2019-08-02 | 10Q | QUBT/Quantum Computing Quarterly |
2019-06-07 | 10K | QUBT/Quantum Computing Annual |
2019-06-07 | 10Q | QUBT/Quantum Computing Quarterly |
2019-05-14 | 10Q | QUBT/Quantum Computing Quarterly |
Receive QUBT News And Ratings
See the #1 stock for the next 7 days that we like better than QUBT
QUBT Financial Statistics
Sales & Book Value
Annual Sales: | $373K |
---|---|
Cash Flow: | $-6.6M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.83 |
Price / Book: | 11.19 |
Profitability
EPS (TTM): | -0.74000 |
---|---|
Net Income (TTM): | $-68.5M |
Gross Margin: | $112K |
Return on Equity: | -87.97% |
Return on Assets: | -74.52% |
Quantum Computing Earnings Forecast
Key Quantum Computing Financial Ratios
-
The Gross Profit Margin over the past 6 years for QUBT is 30.03%.
-
The Selling, General & Administrative Expenses for QUBT have been equal to 3,949.33% of Gross Profit Margin.
-
The Research & Development expenses have been 3,034.32% of Revenue.
-
The Net Earning history of QUBT is -18,375.87% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Quantum Computing Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | QUBT |
Website: | quantumcomputinginc.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 17.36 |
Quick Ratio: | 17.32 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
QUBT Technical Analysis vs Fundamental Analysis
Buy
59
Quantum Computing (QUBT)
is a Buy
Is Quantum Computing a Buy or a Sell?
-
Quantum Computing stock is rated a BuyThe current Quantum Computing [QUBT] share price is $8.75. The Score for QUBT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.